Header and Body 2

Problem Addressed

Bacterial antibiotic resistance is a major health crisis that results in 23,000 deaths and $55 billion in healthcare expenditures every year in the US alone. The rate of bacterial acquisition of antibiotic resistance outpaces the rate of development of new antibiotics; therefore, there is an urgent need to develop new antibiotic therapies. This technology is a novel, highly effective antibiotic with potential therapeutic applications.